Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

ClinicalTrials.gov ID: NCT02462083

Public ClinicalTrials.gov record NCT02462083. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 3:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the long-term safety of IDP-118 lotion.

Study identification

NCT ID
NCT02462083
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
555 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2015
Primary completion
Jan 30, 2017
Completion
Apr 23, 2017
Last update posted
Jan 26, 2020

2015 – 2017

United States locations

U.S. sites
46
U.S. states
21
U.S. cities
41
Facility City State ZIP Site status
Valeant Site 6 Mobile Alabama 36603
Valeant Site 24 Beverly Hills California 90210
Valeant Site 32 Encinitas California 92023
Valeant Site 27 Encino California 91436
Valeant Site 33 Los Angeles California 90001
Valeant Site 43 Los Angeles California 90002
Valeant Site 45 Sacramento California 94203
Valeant Site 25 San Diego California 92093
Valeant Site 4 San Diego California 92093
Valeant Site 44 Santa Monica California 90401
Valeant Site 36 Santa Rosa California 95401
Valeant Site 10 Englewood Colorado 80113
Valeant Site 3 Boynton Beach Florida 33424
Valeant Site 28 Coral Gables Florida 33134
Valeant Site 1 Miami Florida 33101
Valeant Site 37 North Miami Beach Florida 33160
Valeant Site 13 Sanford Florida 32771
Valeant Site 41 Snellville Georgia 30039
Valeant Site 17 South Bend Indiana 46601
Valeant Site 12 Olathe Kansas 66051
Valeant Site 19 Louisville Kentucky 40201
Valeant Site 14 Louisville Kentucky 40205
Valeant Site 35 Clinton Township Michigan 48036
Valeant Site 34 Detroit Michigan 48201
Valeant Site 16 Warren Michigan 48088
Valeant Site 18 Fridley Minnesota 55421
Valeant Site 31 Omaha Nebraska 68022
Valeant Site 2 East Windsor New Jersey 08520
Valeant Site 29 New York New York 10001
Valeant Site 39 Rochester New York 14603
Valeant Site 5 Portland Oregon 97201
Valeant Site 11 Philadelphia Pennsylvania 19019
Valeant Site 30 Charleston South Carolina 29401
Valeant Site 15 Nashville Tennessee 37115
Valeant Site 9 Dallas Texas 75201
Valeant Site 40 Houston Texas 77001
Valeant Site 8 Houston Texas 77004
Valeant Site 46 Katy Texas 77449
Valeant Site 20 Pflugerville Texas 78660
Valeant Site 21 San Antonio Texas 78201
Valeant Site 7 San Antonio Texas 78202
Valeant Site 22 Webster Texas 77598
Valeant Site 38 Salt Lake City Utah 84101
Valeant Site 23 Lynchburg Virginia 24501
Valeant Site 26 Norfolk Virginia 23501
Valeant Site 42 Spokane Washington 99201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02462083, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 26, 2020 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02462083 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →